Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease?

European Journal of Neurology

Volumn 19, Issue 3, 2012, Pages 494-500

  Chiang, H L ^a   Huang, Y S ^b   Chen, S T ^b   Wu, Y R ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Dopamine dysregulation syndrome; Impulse control disorder; Impulsive compulsive behaviors; Parkinson's disease; Punding

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; DEMENTIA; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT CARE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHIATRIST; SOCIAL ASPECT; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; COMPULSIVE BEHAVIOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; TAIWAN;

EID: 84857040753     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03571.x     Document Type: Article

References (37)

1. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998; 339: 1130-1143.
2. Ferreri F, Agbokou C, Gauthier S. Recognition and management of neuropsychiatric complications in Parkinson's disease. CMAJ 2006; 175: 1545-1552.
3. Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 2007; 20: 484-492.
4. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000; 68: 423-428.
5. O'Sullivan SS, Evans AH, Lees AJ. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs 2009; 23: 157-170.
6. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004; 19: 397-405.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn. Washington, DC: American Psychiatric Association, 2000.
8. Hollander E, Stein DJ. Clinical Manual of Impulse-Control Disorders, 1st edn. Arlington, VA: American Psychiatric Pub., 2006.
9. Alegret M, Junque C, Valldeoriola F, Vendrell P, Marti MJ, Tolosa E. Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70: 394-396.
10. Fan W, Ding H, Ma J, Chan P. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett 2009; 465: 6-9.
11. Lee JY, Kim JM, Kim JW, et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 2010; 16: 202-207.
12. Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 2009; 24: 1561-1570.
13. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
14. McElroy SL, Keck PE Jr, Pope HG Jr, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. J Clin Psychiatry 1994; 55: 242-248.
15. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006; 67: 1254-1257.
16. Miyasaki JM, Al Hassan K, Lang AE, Voon V. Punding prevalence in Parkinson's disease. Mov Disord 2007; 22: 1179-1181.
17. Tisch S, Silberstein P, Limousin-Dowsey P, Jahanshahi M. The basal ganglia: anatomy, physiology, and pharmacology. Psychiatr Clin North Am 2004; 27: 757-799.
18. Robinson TE, Berridge KC. Addiction. Annu Rev Psychol 2003; 54: 25-53.
19. Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005; 65: 1570-1574.
20. Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? Lancet Neurol 2003; 2: 595-604.
21. Pezzella FR, Colosimo C, Vanacore N, et al. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Mov Disord 2005; 20: 77-81.
22. Substance Abuse and Mental Health Services Administration. (accessed 06/12/2011).
23. Bachman JG, Wallace JM Jr, O'Malley PM, Johnston LD, Kurth CL, Neighbors HW. Racial/Ethnic differences in smoking, drinking, and illicit drug use among American high school seniors, 1976-89. Am J Public Health 1991; 81: 372-377.
24. Wallace JM Jr, Bachman JG, O'Malley PM, Johnston LD, Schulenberg JE, Cooper SM. Tobacco, alcohol, and illicit drug use: racial and ethnic differences among U.S. high school seniors, 1976-2000. Public Health Rep 2002; 117(Suppl. 1): S67-S75.
25. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006; 63: 969-973.
26. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000; 95(Suppl. 2): S91-S117.
27. Weintraub D. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. Parkinsonism Relat Disord 2009; 15(Suppl. 3): S110-S113.
28. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595.
29. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003; 61: 422-423.
30. Voon V, Hassan K, Zurowski M, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006; 66: 1750-1752.
31. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006; 21: 2068-2072.
32. Dell'Osso B, Altamura AC, Allen A, Marazziti D, Hollander E. Epidemiologic and clinical updates on impulse control disorders: a critical review. Eur Arch Psychiatry Clin Neurosci 2006; 256: 464-475.
33. Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 2008; 23: 411-415.
34. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61: 348-358.
35. Weiss HD, Hirsch ES, Williams JR, Swearengin L, Marsh L. Detection of impulse control disorders in Parkinson disease patients. Neurologist 2010; 16: 406-407.
36. Black DW, Monahan P, Schlosser S, Repertinger S. Compulsive buying severity: an analysis of Compulsive Buying Scale results in 44 subjects. J Nerv Ment Dis 2001; 189: 123-126.
37. Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand 1989; 79: 136-147.